These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 29574228)

  • 1. A Platform for Preparing Homogeneous Proteinaceous Subvisible Particles With Distinct Morphologies.
    Schack MM; Møller EH; Carpenter JF; Rades T; Groenning M
    J Pharm Sci; 2018 Jul; 107(7):1842-1851. PubMed ID: 29574228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate.
    Li L; Kirkitadze M; Bhandal K; Roque C; Yang E; Carpick B; Rahman N
    Curr Pharm Biotechnol; 2017 Nov; 18(8):638-647. PubMed ID: 28914197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products.
    Zhang L; Shi S; Antochshuk V
    J Pharm Sci; 2017 Nov; 106(11):3215-3221. PubMed ID: 28625725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Infrared Microscopy to Assess Secondary Structure of Insulin Molecules Within Individual Subvisible Particles in Aqueous Formulations.
    Schack MM; Møller EH; Friderichsen AV; Carpenter JF; Rades T; Groenning M
    J Pharm Sci; 2019 Mar; 108(3):1117-1129. PubMed ID: 30773199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations.
    Gikanga B; Hui A; Maa YF
    PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy.
    Narhi LO; Corvari V; Ripple DC; Afonina N; Cecchini I; Defelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Spitznagel TM; Weiskopf A; Wuchner K
    J Pharm Sci; 2015 Jun; 104(6):1899-1908. PubMed ID: 25832583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Subvisible Particle Formation in Lyophilized Intravenous Immunoglobulin Formulations Containing Polysorbate 20.
    Zhou C; Qi W; Lewis EN; Randolph TW; Carpenter JF
    J Pharm Sci; 2016 Aug; 105(8):2302-9. PubMed ID: 27290624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of Two Methods for Preparative Fractionation of Proteinaceous Subvisible Particles--Differential Centrifugation and FACS.
    Boll B; Folzer E; Finkler C; Huwyler J; Mahler HC; Schmidt R; Koulov AV
    Pharm Res; 2015 Dec; 32(12):3952-64. PubMed ID: 26195006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation, Characterization and Discriminant Analysis of Subvisible Particles in Biologics Formulations.
    Akhunzada ZS; Hubert M; Sahin E; Pratt J
    Curr Pharm Biotechnol; 2019; 20(3):232-244. PubMed ID: 30767738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein Nanoparticles Promote Microparticle Formation in Intravenous Immunoglobulin Solutions During Freeze-Thawing and Agitation Stresses.
    Pardeshi NN; Zhou C; Randolph TW; Carpenter JF
    J Pharm Sci; 2018 Jul; 107(7):1852-1857. PubMed ID: 29601840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring of subvisible particles in therapeutic proteins.
    Singh SK; Toler MR
    Methods Mol Biol; 2012; 899():379-401. PubMed ID: 22735966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process.
    Salmaso S; Elvassore N; Bertucco A; Caliceti P
    J Pharm Sci; 2009 Feb; 98(2):640-50. PubMed ID: 18484622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subvisible Particles in IVIg Formulations Activate Complement in Human Serum.
    Chisholm CF; Behnke W; Pokhilchuk Y; Frazer-Abel AA; Randolph TW
    J Pharm Sci; 2020 Jan; 109(1):558-565. PubMed ID: 31672401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive Chemical Modifications in the Primary Protein Structure of IgG1 Subvisible Particles Are Necessary for Breaking Immune Tolerance.
    Boll B; Bessa J; Folzer E; Ríos Quiroz A; Schmidt R; Bulau P; Finkler C; Mahler HC; Huwyler J; Iglesias A; Koulov AV
    Mol Pharm; 2017 Apr; 14(4):1292-1299. PubMed ID: 28206769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality by design - Spray drying of insulin intended for inhalation.
    Maltesen MJ; Bjerregaard S; Hovgaard L; Havelund S; van de Weert M
    Eur J Pharm Biopharm; 2008 Nov; 70(3):828-38. PubMed ID: 18755270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.
    Corvari V; Narhi LO; Spitznagel TM; Afonina N; Cao S; Cash P; Cecchini I; DeFelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Weiskopf A; Wuchner K
    Biologicals; 2015 Nov; 43(6):457-73. PubMed ID: 26324466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions.
    Daniels AL; Randolph TW
    J Pharm Sci; 2018 May; 107(5):1313-1321. PubMed ID: 29409840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Submicron polymeric particles accelerate insulin fibrillation by surface adsorption.
    Khosravi Z; Sharma S; Farnoud AM
    Biointerphases; 2019 Mar; 14(2):021001. PubMed ID: 30841701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Differentiation of Protein Aggregates From Other Subvisible Particles in Viscous Mixtures Through Holographic Characterization.
    Winters A; Cheong FC; Odete MA; Lumer J; Ruffner DB; Mishra KI; Grier DG; Philips LA
    J Pharm Sci; 2020 Aug; 109(8):2405-2412. PubMed ID: 32439328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.